Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171320002> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3171320002 endingPage "134" @default.
- W3171320002 startingPage "129" @default.
- W3171320002 abstract "Glioblastoma (GBM) is one of the most malignant brain tumors and requires the formation of new blood vessels, called angiogenesis, for its growth and metastasis. Several proangiogenic factors, including vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF), stimulate GBM angiogenesis. Accordingly, blocking the angiogenesis induced by angiogenic factors represents a promising modality for the treatment of GBM. In this study, we evaluated the inhibitory effects of berbamine, a plant-derived compound, on the angiogenesis induced by VEGF and BDNF in human umbilical vein endothelial cells (HUVECs). Berbamine effectively inhibited the angiogenic features stimulated by VEGF (such as proliferation, adhesion, invasion, tube formation, and reactive oxygen species (ROS) generation in HUVECs) as well as those by BDNF, at concentrations that do not affect endothelial cell viability. The antiangiogenic effects of berbamine were associated with the downregulation of VEGF/VEGF receptor 2 (VEGFR2)/Ca2+/calmodulin-dependent protein kinase IIγ (CaMKIIγ) and BDNF/tropomyosin receptor kinase B (TrkB)/CaMKIIγ signaling pathways. In addition, berbamine suppressed the expression of a key regulator of tumor angiogenesis, hypoxia-inducible factor-1α (HIF-1α), and its transcriptional target, VEGF, in U87MG GBM cells. Furthermore, berbamine significantly inhibited in vivo neovascularization as well as U87MG tumor growth in a chick embryo chorioallantoic membrane (CAM) model. All these findings suggest that berbamine may be utilized as a new antiangiogenic agent for the treatment of malignant brain tumors." @default.
- W3171320002 created "2021-06-22" @default.
- W3171320002 creator A5003570505 @default.
- W3171320002 creator A5004363965 @default.
- W3171320002 creator A5032163811 @default.
- W3171320002 date "2021-08-01" @default.
- W3171320002 modified "2023-10-09" @default.
- W3171320002 title "Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma" @default.
- W3171320002 cites W1603871693 @default.
- W3171320002 cites W1845986149 @default.
- W3171320002 cites W1971279082 @default.
- W3171320002 cites W1976105081 @default.
- W3171320002 cites W1981182976 @default.
- W3171320002 cites W1990931238 @default.
- W3171320002 cites W1992112921 @default.
- W3171320002 cites W2000753244 @default.
- W3171320002 cites W2017583361 @default.
- W3171320002 cites W2023481807 @default.
- W3171320002 cites W2023853595 @default.
- W3171320002 cites W2030537668 @default.
- W3171320002 cites W2061580712 @default.
- W3171320002 cites W2071137865 @default.
- W3171320002 cites W2104105395 @default.
- W3171320002 cites W2110795584 @default.
- W3171320002 cites W2126752700 @default.
- W3171320002 cites W2135251891 @default.
- W3171320002 cites W2144707486 @default.
- W3171320002 cites W2167011180 @default.
- W3171320002 cites W2167961416 @default.
- W3171320002 cites W2170193835 @default.
- W3171320002 cites W2324677651 @default.
- W3171320002 cites W2484753938 @default.
- W3171320002 cites W2560335309 @default.
- W3171320002 cites W2763755167 @default.
- W3171320002 cites W2899267761 @default.
- W3171320002 cites W3045640133 @default.
- W3171320002 cites W78334752 @default.
- W3171320002 doi "https://doi.org/10.1016/j.bbrc.2021.06.025" @default.
- W3171320002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34119825" @default.
- W3171320002 hasPublicationYear "2021" @default.
- W3171320002 type Work @default.
- W3171320002 sameAs 3171320002 @default.
- W3171320002 citedByCount "5" @default.
- W3171320002 countsByYear W31713200022022 @default.
- W3171320002 crossrefType "journal-article" @default.
- W3171320002 hasAuthorship W3171320002A5003570505 @default.
- W3171320002 hasAuthorship W3171320002A5004363965 @default.
- W3171320002 hasAuthorship W3171320002A5032163811 @default.
- W3171320002 hasConcept C167734588 @default.
- W3171320002 hasConcept C185592680 @default.
- W3171320002 hasConcept C2777025900 @default.
- W3171320002 hasConcept C2780394083 @default.
- W3171320002 hasConcept C502942594 @default.
- W3171320002 hasConcept C86803240 @default.
- W3171320002 hasConcept C97230052 @default.
- W3171320002 hasConceptScore W3171320002C167734588 @default.
- W3171320002 hasConceptScore W3171320002C185592680 @default.
- W3171320002 hasConceptScore W3171320002C2777025900 @default.
- W3171320002 hasConceptScore W3171320002C2780394083 @default.
- W3171320002 hasConceptScore W3171320002C502942594 @default.
- W3171320002 hasConceptScore W3171320002C86803240 @default.
- W3171320002 hasConceptScore W3171320002C97230052 @default.
- W3171320002 hasFunder F4320321408 @default.
- W3171320002 hasFunder F4320322030 @default.
- W3171320002 hasFunder F4320322120 @default.
- W3171320002 hasLocation W31713200021 @default.
- W3171320002 hasLocation W31713200022 @default.
- W3171320002 hasOpenAccess W3171320002 @default.
- W3171320002 hasPrimaryLocation W31713200021 @default.
- W3171320002 hasRelatedWork W152235104 @default.
- W3171320002 hasRelatedWork W1646033939 @default.
- W3171320002 hasRelatedWork W2069333676 @default.
- W3171320002 hasRelatedWork W2351076616 @default.
- W3171320002 hasRelatedWork W2401658959 @default.
- W3171320002 hasRelatedWork W2597255643 @default.
- W3171320002 hasRelatedWork W2793242321 @default.
- W3171320002 hasRelatedWork W3182547978 @default.
- W3171320002 hasRelatedWork W4387336235 @default.
- W3171320002 hasRelatedWork W2426130038 @default.
- W3171320002 hasVolume "566" @default.
- W3171320002 isParatext "false" @default.
- W3171320002 isRetracted "false" @default.
- W3171320002 magId "3171320002" @default.
- W3171320002 workType "article" @default.